-

Kyndryl Holdings, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – KD

LOS ANGELES--(BUSINESS WIRE)--The DJS Law Group announces that it is investigating claims on behalf of investors of Kyndryl Holdings, Inc. (“Kyndryl” or “the Company”) (NYSE: KD) for violations of the securities laws.

INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors. Barron’s reported on February 9, 2026, that Kyndryl shares “tumbled early Monday after the company said its chief financial officer was leaving amid an accounting review and it reported weaker earnings than expected.” Based on this news, shares of Kyndryl fell by more than 55% in morning trading on February 9, 2026.

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group’s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Contacts

David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com

The DJS Law Group

NYSE:KD

Release Summary
Kyndryl Holdings, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – KD
Release Versions

Contacts

David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com

More News From The DJS Law Group

Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – RARE

LOS ANGELES--(BUSINESS WIRE)--Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – RARE...

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MREO

LOS ANGELES--(BUSINESS WIRE)--Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MREO...

Oracle Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ORCL

LOS ANGELES--(BUSINESS WIRE)--Oracle Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ORCL...
Back to Newsroom